Tau Consortium

Partnerships & Initiatives

We encourage collaboration across the various stakeholders in academia, government, industry, and philanthropic organizations to accelerate the development of new treatments for tauopathies. The Tau Consortium forges creative new partnerships and provides leadership for several special initiatives that aim to push the pace of medical research.

Some of our collaborative initiatives are linked below:

• Biomarkers Consortium – Neurofilament as a Blood-Based Biomarker of Neurodegeneration in FTD with the Foundation for the National Institutes of Health
• Critical Path for Alzheimer’s Disease with the Critical Path Institute
• FTD Disorders Registry
• Neurofilament Light Surveillance Project (NSP) with the Bluefield Project
• Philanthropic Investments in PET Tracers (PIPETTE) with the Michael J. Fox Foundation
• Prime of Life Brain Initiative and the PSP Genetics Consortium with CurePSP
• Rainwater Prize Program by The Rainwater Charitable Foundation
• Tauopathy Challenge Workshop facilitated by The Rainwater Charitable Foundation
• The Tau Pipeline Enabling Program (T-PEP) with the Alzheimer’s Association